Skip to Content

Erymax 250mg (Erythromycin Delayed-Release 250 mg)

Pill with imprint Erymax 250mg is Orange / Clear, Capsule-shape and has been identified as Erythromycin Delayed-Release 250 mg. It is supplied by Midlothian Laboratories.

Erythromycin is used in the treatment of skin or soft tissue infection; dental abscess; upper respiratory tract infection; bronchitis; bacterial endocarditis prevention (and more), and belongs to the drug class macrolides. There is no proven risk in humans during pregnancy. Erythromycin 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Erymax 250mg

Erythromycin Delayed-Release

Imprint:
Erymax 250mg
Strength:
250 mg
Color:
Orange / Clear
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Macrolides
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Midlothian Laboratories
National Drug Code (NDC):
68308-0250

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide